Madison Vaccines Overview
- Year Founded
-
2012
- Status
-
Out of Business
- Employees
-
2
- Latest Deal Type
-
Out of Business
Madison Vaccines General Information
Description
Developer of immune-activating therapies intended to treat prostate cancer. The company's immune-activating therapies stimulate immune system to destroy residual tumor cells before they develop into overt bone metastases and to delay the need for castration therapies, enabling patients to get cured at an early stage of cancer and avail a healthy life.
Contact Information
Website
www.madisonvaccinesinc.comCorporate Office
- 505 South Rosa Road
- Suite 201
- Madison, WI 53719
- United States
Corporate Office
- 505 South Rosa Road
- Suite 201
- Madison, WI 53719
- United States
Madison Vaccines Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 01-Sep-2017 | Completed | Out of Business | |||
| 3. Early Stage VC (Series A) | 10-Mar-2015 | Completed | Clinical Trials - Phase 2 | |||
| 2. Grant | 27-Aug-2014 | $1.5M | $8M | Completed | Clinical Trials - Phase 2 | |
| 1. Early Stage VC (Series A) | 14-Jan-2014 | $8M | $8M | Completed | Clinical Trials - Phase 2 |
Madison Vaccines Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Madison Vaccines Comparisons
Industry
Financing
Details
Madison Vaccines Competitors (7)
One of Madison Vaccines’s 7 competitors is ImmunOs Therapeutics, a Venture Capital-Backed company based in Schlieren, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ImmunOs Therapeutics | Venture Capital-Backed | Schlieren, Switzerland | ||||
| Istesso | Private Equity-Backed | London, United Kingdom | ||||
| Cardior | Formerly VC-backed | Hannover, Germany | ||||
| NeRRe Therapeutics | Venture Capital-Backed | Stevenage, United Kingdom | ||||
| Arvinas | Formerly VC-backed | New Haven, CT |
Madison Vaccines Patents
Madison Vaccines Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2020218259-A1 | Cancer therapy | Inactive | 08-Feb-2019 | ||
| CA-3129407-A1 | Cancer therapy | Pending | 08-Feb-2019 | ||
| EP-3923980-A1 | Cancer therapy | Pending | 08-Feb-2019 | ||
| EP-3923980-A4 | Cancer therapy | Pending | 08-Feb-2019 | ||
| US-20220133873-A1 | Cancer therapy | Pending | 08-Feb-2019 | C07K16/2818 |
Madison Vaccines Signals
Madison Vaccines FAQs
-
When was Madison Vaccines founded?
Madison Vaccines was founded in 2012.
-
Where is Madison Vaccines headquartered?
Madison Vaccines is headquartered in Madison, WI.
-
What is the size of Madison Vaccines?
Madison Vaccines has 2 total employees.
-
What industry is Madison Vaccines in?
Madison Vaccines’s primary industry is Therapeutic Devices.
-
Is Madison Vaccines a private or public company?
Madison Vaccines is a Private company.
-
What is Madison Vaccines’s current revenue?
The current revenue for Madison Vaccines is .
-
How much funding has Madison Vaccines raised over time?
Madison Vaccines has raised $19M.
-
Who are Madison Vaccines’s competitors?
ImmunOs Therapeutics, Istesso, Cardior, NeRRe Therapeutics, and Arvinas are some of the 7 competitors of Madison Vaccines.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process